The anterior pituitary content of neuromedin U-like immunoreactivity is altered by thyrotrophin-releasing hormone and thyroid hormone status in the rat

in Journal of Endocrinology
Authors:
J. Domin
Search for other papers by J. Domin in
Current site
Google Scholar
PubMed
Close
,
J. H. Steel
Search for other papers by J. H. Steel in
Current site
Google Scholar
PubMed
Close
,
N. Adolphus
Search for other papers by N. Adolphus in
Current site
Google Scholar
PubMed
Close
,
J. M. Burrin
Search for other papers by J. M. Burrin in
Current site
Google Scholar
PubMed
Close
,
U. Leonhardt
Search for other papers by U. Leonhardt in
Current site
Google Scholar
PubMed
Close
,
J. M. Polak
Search for other papers by J. M. Polak in
Current site
Google Scholar
PubMed
Close
, and
S. R. Bloom
Search for other papers by S. R. Bloom in
Current site
Google Scholar
PubMed
Close
Restricted access
Rent on DeepDyve

Sign up for journal news

ABSTRACT

In this study we have examined the effects of TRH, thyroid hormones and dopamine on the rat anterior pituitary content of neuromedin U-like immunoreactivity. Oral administration of TRH (20 mg/100 g per day) to euthyroid animals evoked a fivefold increase in peptide content after 12 days of treatment. This effect was found to be dependent upon circulating levels of thyroid hormone, since administration of TRH to thyroidectomized animals failed to show a similar effect without simultaneous treatment with tri-iodothyronine. The possibility that the TRH-induced increase in anterior lobe neuromedin U content reflected alterations in prolactin secretion or synthetic rate was also examined. Treatment of euthyroid animals with a dopamine agonist and antagonist was, however, without effect. These results demonstrate a unique relationship between TRH and thyroid hormone levels in increasing the anterior lobe content of neuromedin U immunoreactivity.

Journal of Endocrinology (1989) 122, 471–476

 

  • Collapse
  • Expand